Ewa Chodurek

Prof. Dr. Ewa Chodurek

Department of Biopharmacy, Medical University of Silesia, Katowice, Śląskie, Poland
orcid

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 July 2024 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
David AebisherDavid Aebisher
David Aebisher
ISIga Serafin
Iga Serafin
KBKatarzyna Batóg-Szczęch
Katarzyna Batóg-Szczęch
KDKlaudia Dynarowicz
Klaudia Dynarowicz
Ewa ChodurekEwa Chodurek
Ewa Chodurek
Dorota Bartusik-AebisherDorota Bartusik-Aebisher
Dorota Bartusik-Aebisher
Photodynamic therapy (PDT) is a promising cancer treatment method that uses photosensitizing (PS) compounds to selectively destroy tumor cells using laser light. This review discusses the main advantages of PDT, such as its low invasiveness, minimal systemic toxicity and low risk of complications. Special attention is paid to photosensitizers obtained by chemical synthesis. Three generations of photosensitizers are presented, starting with the first, based on porphyrins, through the second generation, including modified porphyrins, chlorins, 5-aminolevulinic acid (ALA) and its derivative hexyl aminolevulinate (HAL), to the third generation, which is based on the use of nanotechnology to increase the selectivity of therapy. In addition, current research trends are highlighted, including the search for new photosensitizers that can overcome the limitations of existing therapies, such as heavy-atom-free nonporphyrinoid photosensitizers, antibody–drug conjugates (ADCs) or photosensitizers with a near-infrared (NIR) absorption peak. Finally, the prospects for the development of PDTs are presented, taking into account advances in nanotechnology and biomedical engineering. The references include both older and newer works. In many cases, when writing about a given group of first- or second-generation photosensitizers, older publications are used because the properties of the compounds described therein have not changed over the years. Moreover, older articles provide information that serves as an introduction to a given group of drugs.

23 June 2022 in Nutrients
Verified
Journal Article
Open access
PDF file
Robert KubinaRobert Kubina
Robert Kubina
KKKamil Krzykawski
Kamil Krzykawski
Agata Kabala-DzikAgata Kabala-Dzik
Agata Kabala-Dzik
Robert D. WojtyczkaRobert D. Wojtyczka
Robert D. Wojtyczka
Ewa ChodurekEwa Chodurek
Ewa Chodurek
Arkadiusz DziedzicArkadiusz Dziedzic
Arkadiusz Dziedzic
Diet plays a crucial role in homeostasis maintenance. Plants and spices containing flavonoids have been widely used in traditional medicine for thousands of years. Flavonols present in our diet may prevent cancer initiation, promotion and progression by modulating important enzymes and receptors in signal transduction pathways related to proliferation, differentiation, apoptosis, inflammation, angiogenesis, metastasis and reversal of multidrug resistance. The anticancer activity of fisetin has been widely documented in numerous in vitro and in vivo studies. This review summarizes the worldwide, evidence-based research on the activity of fisetin toward various types of cancerous conditions, while describing the chemopreventive and therapeutic effects, molecular targets and mechanisms that contribute to the observed anticancer activity of fisetin. In addition, this review synthesized the results from preclinical studies on the use of fisetin as an anticancer agent. Based on the available literature, it might be suggested that fisetin has a bioactive potential to become a complementary drug in the prevention and treatment of cancerous conditions. However, more in-depth research is required to validate current data, so that this compound or its derivatives can enter the clinical trial phase.

21 March 2021 in Molecules
Verified
Journal Article
Open access
PDF file
AKAnna Kaps
Anna Kaps
PGPaweł Gwiazdoń
Paweł Gwiazdoń
Ewa ChodurekEwa Chodurek
Ewa Chodurek
The search for safe and effective anticancer therapies is one of the major challenges of the 21st century. The ineffective treatment of cancers, classified as civilization diseases, contributes to a decreased quality of life, health loss, and premature mortality in oncological patients. Many natural phytochemicals have anticancer potential. Pentacyclic triterpenoids, characterized by six- and five-membered ring structures, are one of the largest class of natural metabolites sourced from the plant kingdom. Among the known natural triterpenoids, we can distinguish lupane-, oleanane-, and ursane-types. Pentacyclic triterpenoids are known to have many biological activities, e.g., anti-inflammatory, antibacterial, hepatoprotective, immunomodulatory, antioxidant, and anticancer properties. Unfortunately, they are also characterized by poor water solubility and, hence, low bioavailability. These pharmacological properties may be improved by both introducing some modifications to their native structures and developing novel delivery systems based on the latest nanotechnological achievements. The development of nanocarrier-delivery systems is aimed at increasing the transport capacity of bioactive compounds by enhancing their solubility, bioavailability, stability in vivo and ensuring tumor-targeting while their toxicity and risk of side effects are significantly reduced. Nanocarriers may vary in sizes, constituents, shapes, and surface properties, all of which affect the ultimate efficacy and safety of a given anticancer therapy, as presented in this review. The presented results demonstrate the high antitumor potential of systems for delivery of pentacyclic triterpenoids.

18 March 2022 in Diagnostics
Verified
Journal Article
Open access
PDF file
WLWojciech Latos
Wojciech Latos
David AebisherDavid Aebisher
David Aebisher
MLMagdalena Latos
Magdalena Latos
MKMagdalena Krupka-Olek
Magdalena Krupka-Olek
KDKlaudia Dynarowicz
Klaudia Dynarowicz
Aleksandra Kawczyk-KrupkaAleksandra Kawczyk-Krupka
Aleksandra Kawczyk-Krupka
Colonoscopy is a fairly common test that serves both diagnostic and therapeutic purposes. It has been considered the gold standard in colorectal cancer screening for several years. Due to the nature of the examination, various types of complications may occur. The purpose of this analysis is to describe the various complications related to the period of preparation for colonoscopy among hospitalized patients, including life-threatening ones, in order to know how to avoid complications while preparing for a colonoscopy. We analyzed the nursing and medical reports of 9962 patients who were prepared for colonoscopy between 2005 and 2016. The frequency of various side effects associated with intensive bowel cleansing prior to colonoscopy was assessed. In justified cases, additional medical data were collected from patients, their families or from other doctors providing advice to patients after complications. Out of 9962 patients prepared for colonoscopy, 180 procedures were discontinued due to complications and side effects, and in these cases no colonoscopy was performed. The most common complications were: vomiting; epistaxis; loss of consciousness with head injury; abdominal pain; acute diarrhea; symptoms of choking; heart rhythm disturbances; dyspnea; fractures of limbs and hands; acute coronary syndrome; hypotension; hypertension; cerebral ischemia; severe blood glucose fluctuations; increased muscle contraction and allergic reactions. In addition to the documentation of our own research, several works of other research groups were also analyzed. Currently, the literature does not provide data on the frequency and type of complications in the preparation period for colonoscopy. The advantage of our work is the awareness of the possibility of serious complications and postulating the necessary identification of threats. Individualization of the recommended procedures and increased supervision of patients undergoing bowel cleansing procedure, we hope, will reduce the occurrence of complications and side effects.

1 September 2000 in Journal of Analytical and Applied Pyrolysis
Verified
Journal Article
Closed access
MLMałgorzata Latocha
Małgorzata Latocha
Ewa ChodurekEwa Chodurek
Ewa Chodurek
SKSlawomir Kurkiewicz
Slawomir Kurkiewicz
LŚL Świątkowska
L Świątkowska
TWT Wilczok
T Wilczok

1 December 1997 in Research in Microbiology
Verified
Journal Article
Closed access
ZDZ. Dzierzewicz
Z. Dzierzewicz
BCBeata Cwalina
Beata Cwalina
Ewa ChodurekEwa Chodurek
Ewa Chodurek
TWT. Wilczok
T. Wilczok